12 Health Care Stocks Moving In Monday's After-Market Session
iBio Inc IBIO
$1.40
▲ +0.72%
(+$0.01)
Open
$1.41
Prev Close
$1.39
Day Range
$1.34 – $1.47
52W Range
$0.56 – $3.82
Market Cap
$69.55M
Beta
1.30
EPS (TTM)
$-0.83
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 2008-08-18 |
| Shares Out. | 49,680,000 |
| Website | ibioinc.com/ ↗ |
| Phone | 18009279800 |
| Employees | 20 |
| Net Income | -$7.8M |
| Free Cash Flow | -$22.2M |
| Total Assets | $85.8M |
| Total Liabilities | $8.3M |
| Equity | $77.5M |
About iBio Inc
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
iBio Inc is a publicly traded company under the ticker symbol IBIO on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-07-01)